Human Reproduction, Vol 12, 1094-1097, Copyright © 1997 by Oxford University Press
J Balasch, JC Reverter, F Fabregues, D Tassies, M Rafel, M Creus and JA Vanrell
The present study was undertaken to investigate the possible association
between activated protein C resistance and first-trimester repeated
abortion. Fifty-five consecutive patients with unexplained first-trimester
repeated abortion and 50 healthy control women having at least one child
but no previous abortion were included. Activated protein C resistance was
measured in all subjects and factor V Leiden genotype testing was performed
in those individuals with phenotypic activated protein C resistance. One
patient with first-trimester repeated abortion and one control subject had
phenotypic activated protein C resistance. Genotype analysis confirmed that
both subjects were heterozygous for factor V Leiden. Our results indicate
that first- trimester repeated abortion is not associated with activated
protein C resistance. Factor V Leiden screening in first-trimester repeated
abortion is not warranted.
ARTICLES
First-trimester repeated abortion is not associated with activated protein C resistance
Department of Obstetrics and Gynaecology, Faculty of Medicine- University of Barcelona, Hospital Clinic i Provincial, Spain.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
F. Dawood, R. Mountford, R. Farquharson, and S. Quenby Genetic polymorphisms on the factor V gene in women with recurrent miscarriage and acquired APCR Hum. Reprod., September 1, 2007; 22(9): 2546 - 2553. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Lynch, K. B. Nelson, C. J. Curry, and J. K. Grether Cerebrovascular Disorders in Children With the Factor V Leiden Mutation J Child Neurol, October 1, 2001; 16(10): 735 - 744. [Abstract] [PDF] |
||||
![]() |
J. R. Meinardi, S. Middeldorp, P. J. de Kam, M. M.W. Koopman, E. C.M. van Pampus, K. Hamulyak, M. H. Prins, H. R. Buller, and J. van der Meer Increased Risk for Fetal Loss in Carriers of the Factor V Leiden Mutation Ann Intern Med, May 4, 1999; 130(9): 736 - 739. [Abstract] [Full Text] [PDF] |
||||


